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Abstract
Using a highly sensitive quantitative RT-PCR method for the
measurement of CYP11B1 (11b-hydroxylase) and CYP11B2
(aldosterone synthase) mRNAs, we previously demonstrated
thatCYP11B2expressioninthecentralnervoussystem(CNS)
is subject to regulation by dietary sodium. We have now
quantiﬁed the expression of these genes in the CNS of male
Wistar Kyoto (WKY) rats in response to systemic ACTH
infusion, dexamethasone infusion, and to adrenalectomy.
CYP11B1 and CYP11B2 mRNA levels were measured in
total RNA isolated from the adrenal gland and discrete brain
regions using real-time quantitative RT-PCR. ACTH
infusion (40 ng/day for 7 days, NZ8) signiﬁcantly increased
CYP11B1 mRNA in the adrenal gland, hypothalamus, and
cerebral cortex compared with animals infused with vehicle
only. ACTH infusion decreased adrenal CYP11B2 expression
but increased expression in all of the CNS regions except the
cortex.Dexamethasone(10 mg/dayfor7days,NZ8)reduced
adrenalCYP11B1mRNAcomparedwithcontrolanimalsbut
had no signiﬁcant effect on either gene’s expression in the
CNS.Adrenalectomy(NZ6pergroup)signiﬁcantlyincreased
CYP11B1 expression in the hippocampus and hypothalamus
and raised CYP11B2 expression in the cerebellum relative to
sham-operated animals. This study conﬁrms the transcription
of CYP11B1 and CYP11B2 throughout the CNS and
demonstrates that gene transcription is subject to differential
regulation by ACTH and circulating corticosteroid levels.
Journal of Endocrinology (2008) 196, 305–311
Introduction
Corticosteroid hormones such as aldosterone and corticos-
terone are synthesized by speciﬁc enzymes in the adrenal
cortex but now there is strong evidence that these enzymes
are also present in other tissues (Davies & MacKenzie 2003).
Although these extra-adrenal sites are not capable of
corticosteroid production on the same scale as the adrenal
cortex, due to a much lower level of relevant gene expression,
their proximity to glucocorticoid receptors (GR) and
mineralocorticoid receptors (MR) is consistent with a
paracrine/autocrine mode of steroid hormone action. We
and others have shown that the brain is a major extra-adrenal
site of corticosteroid production (Gomez-Sanchez et al. 1997,
MacKenzie et al. 2000a). The genes for all of the enzymes
required to form aldosterone and corticosterone de novo from
cholesterol are transcribed, including those of such early
pathway enzymes as the steroidogenic acute regulatory
protein, the side-chain cleavage enzyme (P450scc), and
3b-hydroxysteroid dehydrogenase (3b-HSD; Furukawa
et al. 1998). Furthermore, we have shown that the enzymes
that perform the terminal stages of corticosteroid biosyn-
thesis, aldosterone synthase, and 11b-hydroxylase are
themselves present in rat brain (MacKenzie et al. 2000a).
These studies showed expression of all these genes to occur in
areas throughout the brain, with expression strongest within
the hippocampus and dentate gyrus as well as the cerebellar
granule layer and Purkinje cells.
In the rat, 11b-hydroxylase (CYP11B1) and aldosterone
synthase (CY11B2) convert 11-deoxycorticosterone (DOC)
to corticosterone and aldosterone respectively. Their genes,
CYP11B1 and CYP11B2, possess highly homologous coding
regions but differ markedly in their regulation. In the adrenal
cortex, CYP11B1 expression is controlled by adrenocortico-
trophin (ACTH) while CYP11B2 is regulated mainly by the
renin-angiotensinsystem.Intheadrenalcortex,theexpression
of these genes is subject to strict zonation: CYP11B2 is
conﬁned to the zona glomerulosa and CYP11B1 to the
zona fasciculata/reticularis. ACTH increases CYP11B2
expression acutely but long-term administration of high
doses results in regression of the zona glomerulosa and
theconsequentsuppressionof aldosterone synthaseexpression
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ofCYP11B1andCYP11B2expressionappearstobeidentical,
so that the two enzymes are present within the same cells,
such as the cerebellar granule layer and Purkinje cells
(MacKenzie et al. 2000a).
WepreviouslydevelopedaquantitativeRT-PCRmethodfor
accurate, sensitive measurement of CYP11B1 and CYP11B2
mRNA in brain tissue. The detection limit of 100 copies/mg
total RNA permitted the detection of both CYP11B1 and
CYP11B2 transcription throughout the rat brain and revealed
that local CYP11B2 transcription increases in response to
dietary sodium restriction (Ye et al.2 0 0 3 ). Furthermore,
although the presence of CYP11B2 transcripts was clearly
demonstrable in brain stem, cerebral cortex, hippocampus,
hypothalamus, and cerebellum, CYP11B2 expression only
respondedtodietarysodiumrestrictioninthehippocampusand
thecerebellum,suggestingthatregulationmayvarythroughout
the brain.
Theaimofthisstudywastoextendourpreviousobservations
by comparing and contrastingtheeffects ofsystemicinfusionof
ACTH and dexamethasone on CYP11B1 and CYP11B2
expression in the adrenal gland and central nervous system
(CNS). In addition, the effect of adrenalectomy on central
CYP11B1 and CYP11B2 expression was also studied.
Materials and Methods
Experimental animals
The authors conﬁrm that all animal experimentation
described in this paper was conducted in accord with
accepted standards of humane animal care and UK legal
requirements.
ACTH and dexamethasone infusion
Three groups of adult male Wistar rats (250–300 g, NZ8),
fed on normal chow (Special Diet Services Ltd, Witham,
Essex, UK), were infused with normal saline vehicle, ACTH
(40 ng/day) or dexamethasone (10 mg/day) via Alzet osmotic
minipumps model 2002 (pump rate 0.5 ml/h, Alzet osmotic
minipumps, Cupertino, CA, USA) for 7 days. Blood pressure
was recorded by tail cuff plethysmography and rats were
weighed before and at the end of treatment.
Adrenalectomy and tissue collection
Adrenal glands were removed from 12-week-old male WKY
rats (NZ6). Another group of six animals was subjected to
sham operation as a control. Post-operation, the animals were
maintained for 7 days on normal chow (Special Diet Services
Ltd) and were given 0.154 M sodium chloride to drink.
On completion of experiments, the animals were killed
by decapitation and trunk blood was collected for the assay
of plasma renin activity (PRA). The adrenal glands,
hippocampus, cerebellum, hypothalamus, brain stem, and
cerebral cortex were removed, cleaned, weighed, and frozen
at K70 8C for RNA isolation.
Plasma and fecal analyses
PRA and steroid concentration were measured as previously
described (Ye et al.2 0 0 5 ). Fecal steroids were measured by a
modiﬁed version of the method of Pihl & Hau (2003).B r i e ﬂ y ,
fecal pellets were collected daily into preweighed 50 or 100 ml
tubes and stored at K20 8C until analyzed. Each 24 h sample
was homogenized by a hand-held disperser, Ultra-Turrax T8
(IKA Werke GmbH & Co. KG, Janke & Kunkel Str. 10,
D-79219 Staufen, Germany) in four volumes of H2O.
Approximately 1 g of homogenate was extracted twice with
ﬁve volumes of dichloromethane (CH2Cl2) and then washed
once with one volume of NaOH (0.1 M) and twice with one
volumeofdH2O.Thedichloromethaneextractwasdrieddown
under a stream of nitrogen and reconstituted in assay buffer.
Corticosterone (B) and aldosterone were measured by RIA.
Total RNA isolation
Tissues were homogenized using a RiboLyzer cell disruptor
(Hybaid, Middlesex, UK) and total tissue RNA was isolated
using RNABee (200 mg/ml; Biogenesis, Poole, UK). RNA
was treated with DNase (DNA-free, Ambion, Austin, TX,
USA) and its quality was conﬁrmed by electrophoresis on
agarose gels. RNA concentration was measured using the
RiboGreen RNAQuantitation Kit (Molecular Probes, Leiden
The Netherlands) and a Wallac Victor2 1420 Multilabel
Counter (Perkin–Elmer, Waltham, MA, USA).
Real-time quantitative reverse transcriptase-PCR (qRT-PCR)
CYP11B1 and CYP11B2 mRNA levels were measured using
the Roche LightCycler and external homologous RNA
standards as previously described (Ye et al. 2003). The lower
limit of detection of each assay was 100 copies/mg total RNA.
Each qRT-PCR run consisted of up to 45 PCR cycles;
adrenal and brain sample crossing points were all in the range
of 15–36 cycles. The intra- and inter-assay coefﬁcients of
variation of each assay, calculated using the RT-PCR crossing
point, was !5%.
Data analysis
ACTH infusion increased adrenal weight signiﬁcantly. This
was presumably mainly due to zona fasciculata hypertrophy
and hyperplasia. The calculated CYP11B1 copy numbers for
the infusion experiments were therefore corrected for
changes in tissue mass. The mRNA quantities are presented
both as uncorrected and as copy number/mg total RNA/g
fresh tissue weight. Zona glomerulosa volume would be
expected to decrease but it was not possible to quantify this
accurately. Therefore, adrenal CYP11B2 mRNA expression
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expressed per unit weight of tissue.
Data were analyzed by ANOVA or by Kruskal–Wallis
ANOVA on ranks, when data were not normally distributed
or variance was different between groups. Differences
between speciﬁc mean pairs were analyzed by Tukey’s test
for multiple comparisons or by the Holm–Sidak method. For
all analyses, P!0.05 was required for statistical signiﬁcance.
Data are expressed as the meanGS.E.M.
Results
Effects of ACTH and dexamethasone infusion
ACTH infusion signiﬁcantly decreased body weight
(P!0.01) and increased blood pressure (P!0.01) and adrenal
gland weight (P!0.01) at the time of killing, relative to
vehicle animals (Table 1). PRA in the ACTH-treated animals
was reduced to almost undetectable levels (P!0.05). In
ACTH-treated animals, plasma aldosterone and cortico-
sterone were increased relative to vehicle animals (P!0.01,
Table 1), similar to fecal corticosterone and aldosterone levels
(P!0.001, Fig. 1a and b).
Dexamethasone infusion reduced body weight (P!0.05)
and increased blood pressure (P!0.05) relative to vehicle
animals, but had no effect on adrenal gland weight (Table 1).
Dexamethasone infusion signiﬁcantly suppressed fecal corti-
costerone levels (P!0.001, Fig. 1a). Although there was a
trend towards an increase in PRA with dexamethasone, this
was not statistically signiﬁcant (Table 1).
Table 2 summarizes changes in adrenal gene expression
rates. ACTH infusion increased CYP11B1 mRNA copy
number in adrenal glands (P!0.05), but only when
correction was made for increased adrenal weight. ACTH
decreased CYP11B2 copy number (P!0.01). Dexametha-
sone infusion decreased CYP11B1 mRNA, both corrected
and uncorrected (P!0.05), relative to vehicle-infused
animals but had no signiﬁcant effect on CYP11B2 mRNA.
Expression of CYP11B1 and CYP11B2 mRNA in the brain
are summarized in Fig. 2a and b. ACTH infusion increased
CYP11B1 copy number in the hypothalamus (P!0.05) and
cerebral cortex (P!0.05) relative to vehicle. It also increased
CYP11B2 copy number in the hippocampus, cerebellum,
hypothalamus, and brain stem (all P!0.05). The magnitude of
the increase in CYP11B1 and CYP11B2 copy numbers was
200–300%. Dexamethasone treatment had no signiﬁcant effect
onCYP11B1orCYP11B2expressioninanyregionofthebrain.
Effects of adrenalectomy
Fecalaldosterone andcorticosteronewere signiﬁcantlyreduced
in adrenalectomized animals (both P!0.01), conﬁrming the
success of the procedure (Fig. 3a and b). Adrenalectomy
increased CYP11B1 expression in the hypothalamus (P!0.05)
and hippocampus (P!0.05), and increased CYP11B2
expression in the cerebellum (Fig. 4a and b), although the
magnitudeoftheeffectwasmuchsmallerwith20–25%increase
in copy number.
Discussion
These results conﬁrm thewidespread expression of CYP11B1
and CYP11B2 transcripts in the brain. Although the levels of
mRNA are several orders of magnitude lower than those seen
in the adrenal gland and their abundance varies signiﬁcantly
throughout the rat brain, central CYP11B1 and CYP11B2
expression are subject to transcriptional regulation.
Three experimental manipulations were used in order to
examine this regulation: (i) systemic infusion of ACTH which
mimics stress-induced hypothalamo-pituitary axis (HPA)
activation; (ii) suppression of ACTH by infusion of
dexamethasone; and (iii) elimination of adrenal corticoster-
oids through adrenalectomy.
The effects of these treatments on the adrenal gland were
largely predictable. ACTH infusion signiﬁcantly increased
blood pressure, adrenal weight, and the fecal levels of
corticosterone. Adrenal CYP11B1 transcript number
Table 1 Blood pressures, weights, renin activities, and plasma corticosteroids of vehicle, dexamethasone- and adrenocorticotrophin (ACTH)
treated animals
Vehicle (nZ8) ACTH (nZ8) Dexamethasone (nZ8)
Initial blood pressure (mmHg) 124.1G2.9 120.5G3.0 132.0G3.3
Final blood pressure (mmHg) 134.8G3.7 176.5G6.9 152.5G5.5
†
DBlood pressure (mmHg) 10.7G3.85 6 .0G6.7
† 20.5G4.7*
Initial body weight (g) 294.5G4.6 302.1G6.0 284.8G3.7
Final body weight (g) 332.0G5.0 287.5G9.2 310.2G6.8
DBody weight (g) 37.4G3.9 K14.6G5.7
† 25.3G5.6*
Final adrenal weight (mg) 68.3G3.1 231.7G28.2
† 68.3G9.5
PRA (ng AI/ml per min) 0.29G0.11 0.03G0.02* 0.78G0.20
Plasma aldosterone (pM) 117G65 975G126
† 412G166
Plasma corticosterone (nM) 285G157 3539G680
† 200G77
*P!0.05 relative to vehicle;
†P!0.01 relative to vehicle.
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adrenal mass, which was predominantly zona fasciculata.
This is in agreement with a previous study which also found
no overall adrenal response to ACTH unless adrenal growth
was taken into account (Holland & Carr 1993). While it is
possible that ACTH stimulates CYP11B1 transcription
acutely within each zona fasciculata cell over 7 days ACTH
also causes zona fasciculata cell proliferation (Mitani et al.
1996), thereby reducing the expression rate required of each
individual cell and probably explaining why we saw only a
proportionate increase in CYP11B1 mRNA after adrenal
mass was taken into account.
Chronic ACTH infusion increased fecal and plasma
aldosterone levels while decreasing CYP11B2 transcript levels
in the adrenal gland. Our steroid measurements are in contrast
to those from other studies that showed aldosterone to rise
sharply after ACTH administration but then gradually
decrease over time. However, the present study used lower
concentrations of ACTH and we have veriﬁed that our results
are not attributable to cross-reactivity of the RIA antibody
with other steroids likely to be increased by ACTH, as has
been suggested in other studies (Abayasekara et al. 1993).
ACTH excess is known to reduce zona glomerulosa mass
but this is difﬁcult to quantify (Mazzocchi et al. 1986, Mitani
et al. 1996). Therefore, it is likely that the apparent reduction
in CYP11B2 expression is due in part to a lower proportion
of zona glomerulosa-derived RNA relative to zona fascicu-
lata-derived RNA in ACTH-treated animals. Puriﬁcation of
RNA from isolated adrenal capsules may have given a clearer
indication of zona glomerulosa CYP11B2 expression.
In the CNS, ACTH increased CYP11B1 expression in the
hypothalamusandcerebralcortex.Itispossiblethatthissubserves
a need foraltered local glucocorticoid provision in these regions
or that expression is controlled differently in other regions.
ACTHsigniﬁcantlyincreasedCYP11B2mRNAlevelsinalmost
all of the brain regions we studied. ACTH acts through the
various forms of the melanocortin (MC) receptor and, although
the adrenal form, MC2, has not been detected in the adult rat
brain, there is evidence for the expression of MC3,M C 4,a n d
MC5throughoutthebrain,includingareasofbrainstem,cortex,
amygdala, hippocampus, and cerebellum (reviewed in Adan &
Gispen 1997). However, it is not immediately clear how
systemicallyadministeredACTH couldinﬂuencebrain function
as the blood–brain barrier is assumed to be impermeable to
peptides.Somestudiessuggestthatthecircumventricularorgans,
which lack a blood–brain barrier, play an important role in
conveying blood-borne substances and may provide a port for
peptideaccess(Kastinetal.1984,Banksetal.1993,Chikhaleetal.
1994,Ganong2000).Alternatively,ACTH-inducedstimulation
of 11b-hydroxylase may raise circulating levels of DOC and
corticosterone,whichcanenter thebrainandactassubstratesfor
aldosterone synthase (MacKenzie et al. 2000a).
Dexamethasone had no signiﬁcant effect on CYP11B1 or
CYP11B2 transcription in the brain. Dexamethasone
suppresses adrenal corticosterone production which is
expected to lead to reduced occupancy of the brain MR.
However, this so-called hypocorticoid brain state does not
appear to inﬂuence central expression. Dexamethasone is
known to be excluded from the brain by P-glycoproteins in
all but the very highest amounts (Karssen et al. 2001). As the
dosage administered here was not excessive, it is doubtful that
sufﬁcient dexamethasone entered the brain to inﬂuence local
CYP11B1 expression directly.
In the adrenalectomy studies, the success of the surgery was
conﬁrmed by the low post-operative corticosterone levels.
Table 2 Effect of adrenocorticotrophin (ACTH) and dexamethasone infusion on adrenal CYP11B1 and CYP11B2 mRNA levels
Adrenal CYP11B1 Adrenal CYP11B2
n Copies/mg Copies/mg!adrenal weight (g) Copies/mg Adrenal weight (g)
ACTH 7 3.0!10
8G0.3!10
8 6.9!10
7G0.4!10
7*0 .5!10
6G0.1!10
6† 0.231G0.028
Dex 7 1.4!10
8G0.3!10
8*0 .9!10
7G0.3!10
7*7 .9!10
7G11.0!10
6 0.068G0.009
Vehicle 7 2.8!10
8G0.4!10
8 1.9!10
7G0.4!10
7 7.5!10
7G13.0!10
6 0.068G0.003
*P!0.05;
†P!0.01.
Figure 1 (a and b) Effect of ACTH and dexamethasone infusion on
fecal corticosterone and aldosterone production.
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possiblyother tissues might account for the extremely low but
nonetheless detectable levels of fecal steroid (Mueller et al.
2007). Adrenalectomy caused small but signiﬁcant increases in
CYP11B1mRNAlevelsinthehippocampusandhypothalamus
and CYP11B2 mRNA levels in the cerebellum. It is expected
that adrenalectomy would result in increased plasma levels of
ACTH.However,theseeffectsareclearlydifferentfromthoseof
ACTH infusion in both their region speciﬁcity and the
m a g n i t u d eo fr e s p o n s e .T h eo v e r a l ll a c ko fc h a n g ei n
CYP11B2 expression may be due to the provision of saline
following surgery, which would maintain normal PRA and
angiotensin II, although these were not measured. However, as
with dexamethasone, it seems apparent that induction of a
hypocorticoid state has a lesser effect on the CYP11B1 and
CYP11B2 expression in the CNS.
When analyzing levels of mRNAwithin a tissue, studies are
open to the criticism that variations in transcription may not
feed through to differences in enzyme level, or that the real
limiting factor in the pathway may lie elsewhere. An elegant
study by Gomez-Sanchez et al.( 2 0 0 5 )demonstrated that
providing DOC to adrenalectomized rats did not result in any
detectable levels of brain corticosterone; the authors logically
tookthisasanindicationthatlevelsof11b-hydroxylase,andnot
substrate, was the factor limiting corticosterone production in
these animals. However, if local corticosteroid biosynthesis is a
real phenomenon within the CNS, that study did raise the
question of why no corticosterone could be detected at all,
rather thansimplya reductionrelative to the intact animals.We
suspect that the reason the authors could not see any
corticosterone following adrenalectomy was twofold. First,
thelowlocalproductionofsteroidwithindiscretebrainregions
will be further diluted when analyzed in a whole brain extract
consisting of expressing and non-expressing cells, such as that
employed by Go `mez-Sa ´nchez et al. Second, our studies on
the brain tend to suggest that aldosterone synthase and
11b-hydroxylase are co-expressed within the brain. Since
both enzymes have a common substrate, DOC, and any
corticosterone produced by 11b-hydroxylase is a potential
substrateforaldosteronesynthase,thenonemightexpecttoseea
more signiﬁcant rise in aldosterone which was detected by
Go `mez-Sa ´nchez et al. in the brains of adrenalectomized rats. It
further follows that there will be marked regional variation in
brain tissue levels of aldosterone and corticosterone if output is
related to the relative ratios of these two enzymes.
This study conﬁrms the differential expression of CYP11B1
andCYP11B2genesinvariousregionsoftheCNSandsupports
Figure 2 (a and b) Effect of ACTH and dexamethasone infusion on
central CYP11B1 and CYP11B2 mRNA levels. *P!0.05; **P!0.01.
Figure 3 (a and b) Effect of adrenalectomy (ADX) on fecal
corticosterone and aldosterone production.
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that aldosterone and corticosterone can be synthesized de novo
fromcholesterolintheCNS(Gomez-Sanchezetal.19 96,1997,
MacKenzieetal.2000a,b).Althoughthelevelsofgeneexpression
andthe steroidogenic capacityare much lower than those ofthe
adrenal gland (Gomez-Sanchez et al.1 9 9 7 , Ye et al. 2003), the
presenceofMRandGRintheimmediatevicinitymayfacilitate
autocrine- or paracrine-mediated physiological effects.
What might these effects be? GR are widely distributed
throughout the brain and are associated with a range of
functions. For example, appetite and cognitive function are
controlled by GR, which is expressed at high levels in the
hypothalamus and hippocampus respectively, and both of these
areas mediate feedback control of the HPA axis. Although all
CNS regions that we examined express CYP11B1,i ti s
signiﬁcant that the lowest levels of transcription are associated
with the hypothalamus and hippocampus. Arguably, this
mitigates against the importance of local CYP11B1
transcription in brain glucocorticoid action. However, as
previous immunocytochemical studies of 11-hydroxylase
indicate that expression is localized to particular cell types
within a region, it follows that the CYP11B1 levels that we
report may be diluted by RNA from the majority of non-
expressing cells. The expression of CYP11B1 is highest in the
cortex and brain stem. In the brain stem, GR is present in the
nerve cells nuclei associated withnorepinephrine, epinephrine,
and serotonin. The subcellular translocation of GR from
cytoplasm to nucleus takes place after receptor activation and
might therefore indicate that cells are tonicallyexposed to high
levelsofglucocorticoidhormonewhich,theoretically,couldbe
supplied autonomously by local 11b-hydroxylase activity.
MR is found in high concentrations in the hippocampus,
septum,andinsomebrainstemnucleiandisassociatedwiththe
regulation ofﬂuid homeostasis through effects on thirst and salt
appetite. Central actions of aldosterone have been proposed to
play a role in blood pressure homeostasis. In this respect,
intracerebroventricular (ICV) administration of systemically
ineffective levels of aldosterone signiﬁcantly increases blood
pressure (Gomez-Sanchez 1986). Whether modulation of
blood pressure is mediated by locally synthesized aldosterone
is unclear. However, ICVadministration of 19-ethynyl-DOC,
an inhibitor of aldosterone synthase, prevents the increase in
blood pressure following sodium treatment in the Dahl salt-
sensitive rat suggesting that locally synthesized aldosterone may
be important (Gomez-Sanchez et al.1 9 9 6 ).
How aldosterone mediates these central effects is unclear.
The enzyme 11b-HSD2 which inactivates corticosterone and
protects the MR from occupation by glucocorticoids is only
expressed in the subcommissural organ and nucleus tract
solitarius(Robsonetal.1998).Thismeansthatthevastmajority
of brain MR is non-selective for mineralocorticoid and
glucocorticoid. However, the hypertensive response to ICV
aldosterone can be inhibited by MR blockade, suggesting that
mineralocorticoids can access the MR even in the absence of
11b-HSD2.ItispossiblethatICVadministrationofaldosterone
generates a high local concentration of steroid, allowing it
to compete on more equal terms with glucocorticoid for MR
occupancy. In this way, aldosterone could occupy sufﬁcient
MR in order togenerate a speciﬁc mineralocorticoid response.
Extra-adrenal aldosterone biosynthesis could be a way of
generating similar localized, high concentrations of mineralo-
corticoid within speciﬁc brain regions.
We have previously shown that the CYP11B2 gene is
expressed inspeciﬁc cell types within discrete brainregionsand
that its transcription is regulated by angiotensin II and sodium
(MacKenzie et al.2 0 0 2 ). Using different stimuli, this study
conﬁrmsthatbothCYP11B1andCYP11B2geneexpressionin
the CNS can be regulated, suggesting a biological role for
11b-hydroxylase and aldosterone synthase within the CNS.
While the central role of these enzymes remains largely
unknown, this work represents important progress in the
elucidation of this complex system and demonstrates the need
for further detailed physiological studies.
Figure 4 (a and b) Effect of adrenalectomy (ADX) on central
CYP11B1 and CYP11B2 mRNA levels. *P!0.05.
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